- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 457/06 - Lysergic acid amides
Patent holdings for IPC class C07D 457/06
Total number of patents in this class: 71
10-year publication summary
|
2
|
2
|
4
|
2
|
0
|
5
|
9
|
10
|
9
|
8
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ceruvia Lifesciences LLC | 14 |
7 |
| VeroScience LLC | 68 |
6 |
| Gilgamesh Pharmaceuticals, Inc. | 61 |
6 |
| BetterLife Pharma Inc. | 11 |
6 |
| Florida State University Research Foundation, Inc. | 784 |
4 |
| Terran Biosciences, Inc. | 96 |
4 |
| Lek Pharmaceuticals d.d. | 198 |
3 |
| Pike Therapeutics Inc. | 37 |
3 |
| Regents of the University of Minnesota | 2739 |
2 |
| Theaprin Pharmaceuticals Inc. | 33 |
2 |
| Xoc Pharmaceuticals, Inc. | 11 |
2 |
| Mind Medicine Inc. | 95 |
2 |
| Transcend Biodynamics LLC | 2 |
2 |
| GATC Health Corp | 27 |
2 |
| Mindset Pharma Inc. | 59 |
2 |
| CY Biopharma AG | 6 |
2 |
| Synex Holdings BV | 2 |
2 |
| MAP Pharmaceuticals, Inc. | 54 |
1 |
| Pharmacia Italia S.p.A. | 1 |
1 |
| Ranbaxy Laboratories Limited | 276 |
1 |
| Other owners | 11 |